HTA240 An Evaluation of the Reimbursement Status of CAR-T Cell Therapies in the EU-4 and UK

Abstract

Authors

T. Rodrigues R. Howard S. Brown C. Akesson

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×